Intracellular antibodies (intrabodies) and their therapeutic potential.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Handbook of Experimental Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-3-540-73259-4_15PMID 18071953
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intracranial Adeno-Associated Virus-Mediated Delivery of Anti-Pan Amyloid β, Amyloid β40, and Amyloid β42 Single-Chain Variable Fragments Attenuates Plaque Pathology in Amyloid Precursor Protein Mice

  2006cited by this paper
• Isolation of anti-CD22 Fv with high affinity by Fv display on human cells.

  2006cited by this paper
• Anti-Aβ single chain antibody delivery via adeno-associated virus for treatment of Alzheimer’s disease

  2006cited by this paper
• RNAi in mice: a promising approach to decipher gene functions in vivo.

  2006cited by this paper
• Current strategies and future directions for eluding adenoviral vector immunity.

  2006cited by this paper
• Anti-Abeta single-chain antibody delivery via adeno-associated virus for treatment of Alzheimer's disease.

  2006cited by this paper
• T-cell protection and enrichment through lentiviral CCR5 intrabody gene delivery

  2006cited by this paper
• Therapeutic expression of an anti-death receptor 5 single-chain fixed-variable region prevents tumor growth in mice.

  2006cited by this paper
• An anti-major histocompatibility complex class I intrabody protects endothelial cells from an attack by immune mediators.

  2006cited by this paper
• Targeting lentiviral vectors to specific cell types in vivo.

  2006cited by this paper
• An intracellular antibody can suppress tumorigenicity in Hepatitis B virus X-expressing cells

  2006cited by this paper
• Novel highly efficient intrabody mediates complete inhibition of cell surface expression of the human vascular endothelial growth factor receptor-2 (VEGFR-2/KDR).

  2005cited by this paper
• Cell Type–Specific Targeting with Sindbis Pseudotyped Lentiviral Vectors Displaying Anti-CCR5 Single-Chain Antibodies

  2005cited by this paper
• siRNA therapeutics: big potential from small RNAs

  2005cited by this paper
• Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection

  2005cited by this paper
• Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody).

  2005cited by this paper
• Selecting and screening recombinant antibody libraries

  2005cited by this paper
• Genetic targeting strategies for adenovirus.

  2005cited by this paper
• β-site specific intrabodies to decrease and prevent generation of Alzheimer's Aβ peptide

  2005cited by this paper
• Intrabody applications in neurological disorders: progress and future prospects.

  2005cited by this paper
• Phenotypic knockout of VEGF-R2 and Tie-2 with an intradiabody reduces tumor growth and angiogenesis in vivo.

  2005cited by this paper
• A universal strategy for stable intracellular antibodies.

  2005cited by this paper
• KDEL-tagged anti-prion intrabodies impair PrP lysosomal degradation and inhibit scrapie infectivity.

  2005cited by this paper
• Trapping Prion Protein in the Endoplasmic Reticulum Impairs PrPC Maturation and Prevents PrPSc Accumulation*

  2005cited by this paper
• Suppression of Huntington's disease pathology in Drosophila by human single-chain Fv antibodies.

  2005cited by this paper
• Down-modulation of the CXCR4 co-receptor by intracellular expression of a single chain variable fragment (SFv) inhibits HIV-1 entry into primary human brain microvascular endothelial cells and post-mitotic neurons.

  2005cited by this paper
• Targeting tumor angiogenesis with adenovirus-delivered anti-Tie-2 intrabody.

  2005cited by this paper
• Proapoptotic activity of cell-permeable anti-Akt single-chain antibodies.

  2005cited by this paper
• Potential applications of intracellular antibodies (intrabodies) in stem cell therapeutics

  2005cited by this paper
• Selecting for antibody scFv fragments with improved stability using phage display with denaturation under reducing conditions.

  2005cited by this paper
• Human single-domain neutralizing intrabodies directed against Etk kinase: a novel approach to impair cellular transformation

  2005cited by this paper
• Generation and characterization of single-chain antibody fragments specific against transmembrane envelope glycoprotein gp46 of maedi-visna virus.

  2004cited by this paper
• Potent inhibition of huntingtin aggregation and cytotoxicity by a disulfide bond-free single-domain intracellular antibody.

  2004cited by this paper
• A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed α-synuclein

  2004cited by this paper
• Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120.

  2004cited by this paper
• Decline of surface MHC I by adenoviral gene transfer of anti‐MHC I intrabodies in human endothelial cells—new perspectives for the generation of universal donor cells for tissue transplantation

  2004cited by this paper
• Development of a human light chain variable domain (V(L)) intracellular antibody specific for the amino terminus of huntingtin via yeast surface display.

  2004cited by this paper
• Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block NF-kappaB transactivation.

  2004cited by this paper
• MHC class I manipulation on cell surfaces by gene transfer of anti-MHC class I intrabodies--a tool for decreased immunogenicity of allogeneic tissue and cell transplants.

  2004cited by this paper
• A human single-chain Fv intrabody blocks aberrant cellular effects of overexpressed alpha-synuclein.

  2004cited by this paper
• RNA interference and double-stranded-RNA-activated pathways.

  2004cited by this paper
• Nonspecific, concentration-dependent stimulation and repression of mammalian gene expression by small interfering RNAs (siRNAs).

  2004cited by this paper
• Stability improvement of antibodies for extracellular and intracellular applications: CDR grafting to stable frameworks and structure-based framework engineering.

  2004cited by this paper
• Transduction peptides: from technology to physiology

  2004cited by this paper
• Protecting from R5-tropic HIV: individual and combined effectiveness of a hammerhead ribozyme and a single-chain Fv antibody that targets CCR5

  2004cited by this paper
• Characterization of a single-chain intrabody directed against the human receptor tyrosine kinase Ron.

  2004cited by this paper
• Camelized rabbit-derived VH single-domain intrabodies against Vif strongly neutralize HIV-1 infectivity.

  2004cited by this paper
• αV integrin promotes in vitro and in vivo survival of cells in metastatic melanoma

  2004cited by this paper
• Single domain intracellular antibodies: a minimal fragment for direct in vivo selection of antigen-specific intrabodies.

  2003cited by this paper
• Intracellular antibodies and challenges facing their use as therapeutic agents.

  2003cited by this paper
• Immunity to adenovirus and adeno-associated viral vectors: implications for gene therapy

  2003cited by this paper
• Inhibition of Tat-mediated Transactivation and HIV-1 Replication by Human Anti-hCyclinT1 Intrabodies*

  2003cited by this paper
• Human antibodies from immunized donors are protective against anthrax toxin in vivo

  2003cited by this paper
• Evaluation of risks related to the use of adeno-associated virus-based vectors.

  2003cited by this paper
• Reversion of transformed phenotype in ovarian cancer cells by intracellular expression of anti folate receptor antibodies

  2003cited by this paper
• I ntrabody‐based strategies for inhibition of vascular endothelial growth factor receptor‐2: effects on apoptosis, cell growth, and angiogenesis

  2003cited by this paper
• Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120.

  2003cited by this paper
• Intradiabodies, Bispecific, Tetravalent Antibodies for the Simultaneous Functional Knockout of Two Cell Surface Receptors*

  2003cited by this paper
• Mutant Huntingtin Promotes the Fibrillogenesis of Wild-type Huntingtin

  2003cited by this paper
• Functional inactivation of the conserved Sem1p in yeast by intrabodies

  2003cited by this paper
• Activation of the interferon system by short-interfering RNAs

  2003cited by this paper
• Quantitation of the tumor-targeting properties of antibody fragments conjugated to cell-permeating HIV-1 TAT peptides.

  2002cited by this paper
• Intrabody-mediated phenotypic knockout of major histocompatibility complex class I expression in human and monkey cell lines and in primary human keratinocytes

  2002cited by this paper
• Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity

  2002cited by this paper
• Direct in Vivo Screening of Intrabody Libraries Constructed on a Highly Stable Single-chain Framework*

  2002cited by this paper
• Therapeutic efficacy of anti-ErbB2 immunoliposomes targeted by a phage antibody selected for cellular endocytosis.

  2002cited by this paper
• Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy

  2002cited by this paper
• RNA interference--a new weapon against HIV and beyond.

  2002cited by this paper
• Characterization of anti-cyclin E single-chain Fv antibodies and intrabodies in breast cancer cells: enhanced intracellular stability of novel sFv-F(c) intrabodies.

  2002cited by this paper
• Combination genetic therapy to inhibit HIV-1.

  2002cited by this paper
• Functional Neutralization of HIV-1 Vif Protein by Intracellular Immunization Inhibits Reverse Transcription and Viral Replication*

  2002cited by this paper
• Phage display technology: clinical applications and recent innovations.

  2002cited by this paper
• Stability engineering of antibody single-chain Fv fragments.

  2001cited by this paper
• Fast selection of antibodies without antigen purification: adaptation of the protein fragment complementation assay to select antigen-antibody pairs.

  2001cited by this paper
• Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies.

  2001cited by this paper
• Intracellular Stability of Anti-caspase-3 Intrabodies Determines Efficacy in Retargeting the Antigen*

  2001cited by this paper
• Single-chain antibody-mediated gene delivery into ErbB2-positive human breast cancer cells

  2001cited by this paper
• Optimal Design Features of Camelized Human Single-domain Antibody Libraries*

  2001cited by this paper
• Overcoming multi‐drug resistance using an intracellular anti‐MDR1 sFv

  2001cited by this paper
• Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease

  2001cited by this paper
• Antigen‐independent selection of stable intracellular single‐chain antibodies

  2001cited by this paper
• Functional deletion of the CCR5 receptor by intracellular immunization produces cells that are refractory to CCR5-dependent HIV-1 infection and cell fusion.

  2000cited by this paper
• Harnessing the ubiquitination machinery to target the degradation of specific cellular proteins.

  2000cited by this paper
• Natural and designer binding sites made by phage display technology.

  2000cited by this paper
• Induction of apoptosis by the dsRNA-dependent protein kinase (PKR): Mechanism of action

  2000cited by this paper
• Correlation between in Vitro Stability and in Vivo Performance of Anti-GCN4 Intrabodies as Cytoplasmic Inhibitors*

  2000cited by this paper
• Intracellular antibody-caspase-mediated cell killing: an approach for application in cancer therapy.

  2000cited by this paper
• A cancer gene therapy approach utilizing an anti-erbB-2 single-chain antibody-encoding adenovirus (AD21): a phase I trial.

  2000cited by this paper
• Phage display of antibody fragments.

  2000cited by this paper
• Fully synthetic human combinatorial antibody libraries (HuCAL) based on modular consensus frameworks and CDRs randomized with trinucleotides.

  2000cited by this paper
• Restoration of transcriptional activity of p53 mutants in human tumour cells by intracellular expression of anti-p53 single chain Fv fragments

  1999cited by this paper
• Inhibition of expression of the Galalpha1-3Gal epitope on porcine cells using an intracellular single-chain antibody directed against alpha1,3galactosyltransferase.

  1999cited by this paper
• A tumor specific single chain antibody dependent gene expression system

  1999cited by this paper
• Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7.

  1999cited by this paper
• Depletion of alphaV integrins from osteosarcoma cells by intracellular antibody expression induces bone differentiation marker genes and suppresses gelatinase (MMP-2) synthesis.

  1999cited by this paper
• Inhibition of cytoplasmic antigen, glucose- 6-phosphate dehydrogenase, by VH-CH1, an intracellular Fd fragment antibody derived from a semisynthetic Fd fragment phage display library.

  1999cited by this paper
• Inhibition of expression of the Galα1-3Gal epitope on porcine cells using an intracellular single-chain antibody directed against α1,3Galactosyltransferase

  1999cited by this paper
• Selection of antibodies for intracellular function using a two-hybrid in vivo system.

  1999cited by this paper
• Inhibition of human immunodeficiency virus type 1 replication in vitro in acutely and persistently infected human CD4+ mononuclear cells expressing murine and humanized anti-human immunodeficiency virus type 1 Tat single-chain variable fragment intrabodies.

  1999cited by this paper
• Characterization and binding of intracellular antibody fragments to the hepatitis C virus core protein.

  1999cited by this paper

• mRNA-Encoded Antibodies: An Emerging Paradigm in Antiviral Protection.

  2026cites this paper
• AI-assisted protein design to rapidly convert antibody sequences to intrabodies targeting diverse peptides and histone modifications

  2026cites this paper
• Protein-Based Degraders: From Chemical Biology Tools to Neo-Therapeutics

  2025cites this paper
• Development of a chemically induced dissociation system via phage surface‐displayed nanobody screening

  2025cites this paper
• AI-assisted protein design to rapidly convert antibody sequences to intrabodies targeting diverse peptides and histone modifications

  2025cites this paper
• Therapeutic peptides targeting intracellular molecules

  2024cites this paper
• vNARs as Neutralizing Intracellular Therapeutic Agents: Glioblastoma as a Target

  2024cites this paper
• NbThermo: a new thermostability database for nanobodies

  2023cites this paper
• Production of nanobodies in Andean camelids and their most common applications: A general review in the medical field.

  2023cites this paper
• A Specific Mini‐Intrabody Mediates Lysosome Degradation of Mutant Huntingtin

  2023cites this paper
• Evaluation of variable new antigen receptors (vNARs) as a novel cathepsin S (CTSS) targeting strategy

  2023cites this paper
• Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14del

  2022cites this paper
• In vivo targeted delivery of antibodies into cancer cells with pH-responsive cell-penetrating poly(disulfide)s.

  2022cites this paper
• Structural Insights into the Design of Synthetic Nanobody Libraries

  2022cites this paper
• Monobodies as tool biologics for accelerating target validation and druggable site discovery

  2021cites this paper
• Discovery of Antivirals Using Phage Display

  2021cites this paper
• Seeking a Magic Bullet–the search for new Parkinson’s disease therapeutic agents

  2021cites this paper
• Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy

  2021cites this paper
• Intracellular Delivery of Active Proteins by Polyphosphazene Polymers

  2021cites this paper
• A review on advances of treatment modalities for Alzheimer's disease.

  2021cites this paper
• A comprehensive comparison between camelid nanobodies and single chain variable fragments

  2021cites this paper
• Nanobodies as probes and modulators of cardiovascular GPCRs.

  2021cites this paper
• Engineered Extracellular Vesicles/Exosomes as a New Tool against Neurodegenerative Diseases

  2020cites this paper
• Recent progress in antitumor functions of the intracellular antibodies.

  2020cites this paper
• Single-Domain Antibodies: Biology, Engineering and Emerging Applications

  2020cites this paper
• Characterization of Intrabodies Targeting the hERG Potassium Channel

  2019cites this paper
• The Intracellular Delivery Of Anti-HPV16 E7 scFvs Through Engineered Extracellular Vesicles Inhibits The Proliferation Of HPV-Infected Cells

  2019cites this paper
• BRAIN Initiative: Cutting-Edge Tools and Resources for the Community

  2019cites this paper
• Engineering modular intracellular protein sensor-actuator devices

  2018cites this paper
• Bypassing Endocytosis: Direct Cytosolic Delivery of Proteins.

  2018cites this paper
• Nanoparticles for the delivery of therapeutic antibodies: Dogma or promising strategy?

  2017cites this paper
• Shifting towards a model of mGluR5 dysregulation in schizophrenia: Consequences for future schizophrenia treatment.

  2017cites this paper
• Discovery of Therapeutic Approaches for Polyglutamine Diseases: A Summary of Recent Efforts

  2017cites this paper
• Intracellular Crosslinking of Filoviral Nucleoproteins with Xintrabodies Restricts Viral Packaging

  2017cites this paper
• Nanobody-Based Delivery Systems for Diagnosis and Targeted Tumor Therapy

  2017cites this paper
• Growth signalobody selects functional intrabodies in the mammalian cytoplasm.

  2016cites this paper
• Intracellular targeting with engineered proteins

  2016cites this paper
• Immunotherapy Against α-Synuclein Pathology

  2016cites this paper
• The History of Therapeutic Monoclonal Antibodies

  2016cites this paper
• Inhibiteurs de citrine pour le traitement du cancer

  2016cites this paper
• Intracellularly expressed nanobodies against non-structural protein 4 of porcine reproductive and respiratory syndrome virus inhibit virus replication

  2016cites this paper
• Antibodies inside of a cell can change its outside: Can intrabodies provide a new therapeutic paradigm?

  2016cites this paper
• Cell‐penetrating and endoplasmic reticulum‐locating TAT‐IL‐24‐KDEL fusion protein induces tumor apoptosis

  2016cites this paper
• A Genetically Encoded Probe for Live-Cell Imaging of H4K20 Monomethylation.

  2016cites this paper
• Phenotypic knockouts of selected metabolic pathways by targeting enzymes with camel-derived nanobodies (V(HH)s).

  2015cites this paper
• A Review on: Antibody Engineering for Development of Therapeutic Antibodies

  2015cites this paper
• ER Intrabodies: Potent Molecules for Specific Knockdown of Proteins Passingthe ER

  2015cites this paper
• Engineering Antibody Fragments for Intracellular Applications

  2015cites this paper
• Intrabody-mediated diverting of HP1β to the cytoplasm induces co-aggregation of H3-H4 histones and lamin-B receptor.

  2015cites this paper
• Proteoliposome-based Selection of a Recombinant Antibody Fragment Against the Human M2 Muscarinic Acetylcholine Receptor

  2014cites this paper
• A bispecific transmembrane antibody simultaneously targeting intra‐ and extracellular epitopes of the epidermal growth factor receptor inhibits receptor activation and tumor cell growth

  2014cites this paper
• Regulation of b 2 -Adrenergic Receptor Function by Conformationally Selective Single-Domain Intrabodies s

  2014cites this paper
• Fine Epitope Mapping of the Central Immunodominant Region of Nucleoprotein from Crimean-Congo Hemorrhagic Fever Virus (CCHFV)

  2014cites this paper
• An intrabody specific for the nucleophosmin carboxy-terminal mutant and fused to a nuclear localization sequence binds its antigen but fails to relocate it in the nucleus

  2014cites this paper
• Increasing stability of antibody via antibody engineering: Stability engineering on an anti‐hVEGF

  2014cites this paper
• Sélection et caractérisation d'anticorps et de fragments d'anticorps pour l'immunociblage intracellulaire

  2014cites this paper
• Intrabodies as Neuroprotective Therapeutics

  2013cites this paper
• The use of fluorescent intrabodies to detect endogenous gankyrin in living cancer cells.

  2013cites this paper
• Immunosympathectomy as the first phenotypic knockout with antibodies

  2013cites this paper
• Aptamers: multifunctional molecules for biomedical research

  2013cites this paper
• Can Intrabodies Serve as Neuroprotective Therapies for Parkinson's Disease? Beginning Thoughts

  2013cites this paper
• Regulation of Beta-2-Adrenergic Receptor Function by Conformationally Selective Single-domain Intrabodies

  2013cites this paper
• Generation of antibodies that are externally acting isoform-specific inhibitors of ion channels.

  2013cites this paper
• Gene-Based Antibody Strategies for Prion Diseases

  2013cites this paper
• The intracellular Ig fold: a robust protein scaffold for the engineering of molecular recognition.

  2012cites this paper
• Yeast two-hybrid methods and their applications in drug discovery.

  2012cites this paper
• Detection of biomarkers using recombinant antibodies coupled to nanostructured platforms

  2012cites this paper
• Recombinant rabbit single‐chain antibodies bind to the catalytic and C‐terminal domains of HIV‐1 integrase protein and strongly inhibit HIV‐1 replication

  2012cites this paper
• Use of micro-emulsion technology for the directed evolution of antibodies.

  2012cites this paper
• In Vivo Selection of CD4+ T Cells Transduced with a Gamma-Retroviral Vector Expressing a Single-Chain Intrabody Targeting HIV-1 Tat

  2012influential citation
• Assessing combinatorial strategies to multimerize libraries of single‐domain antibodies

  2012cites this paper
• Targeted Delivery of PLK1-siRNA by ScFv Suppresses Her2+ Breast Cancer Growth and Metastasis

  2012cites this paper
• Novel cell and gene therapies for HIV.

  2012cites this paper
• Bacterial two hybrid: a versatile one-step intracellular selection method.

  2012cites this paper
• Engineered antibody therapies to counteract mutant huntingtin and related toxic intracellular proteins.

  2012cites this paper
• A novel hSH3 domain scaffold engineered to bind folded domains in CD2BP2 and HIV capsid protein.

  2012cites this paper
• Intrabody-based gene therapeutic strategy

  2012cites this paper
• Semele: A Killer-Male, Rescue-Female System for Suppression and Replacement of Insect Disease Vector Populations

  2011cites this paper
• Intrabody Expression in Mammalian Cells

  2011influential citation
• The Generation of Affinity Reagents Using High-throughput Phage Display and Building the Foundations of a Novel High-throughput Intrabody Pipeline

  2011cites this paper
• Anti-FR Antibody Generation and Engineering: Development of New Therapeutic Tools

  2011cites this paper
• Modifying the antigen-immunization schedule improves the variety of monoclonal antibodies obtained from immune-phage antibody libraries against HIV-1 Nef and Vif.

  2011cites this paper
• A disulfide-free single-domain V(L) intrabody with blocking activity towards huntingtin reveals a novel mode of epitope recognition.

  2011cites this paper
• The Influenza Pandemic of 2009

  2011cites this paper
• Targeting antibodies to the cytoplasm

  2011cites this paper
• New ways to control insect pest populations through manipulating inheritance

  2011cites this paper
• The toxin and antidote puzzle

  2011cites this paper
• Recent Advances in Biotherapeutics Drug Discovery and Development

  2011cites this paper
• The influenza pandemic of 2009: lessons and implications.

  2011cites this paper
• Single‐domain llama antibodies as specific intracellular inhibitors of SpvB, the actin ADP‐ribosylating toxin of Salmonella typhimurium

  2011cites this paper
• Antibody expression and production

  2011cites this paper
• Selection for intrabody solubility in mammalian cells using GFP fusions.

  2011cites this paper
• Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons Learnt

  2011cites this paper
• Targeting Cas Family Proteins as a Novel Treatment for Breast Cancer

  2011cites this paper
• A Monoclonal Antibody Against the Oncogenic Mucin 1 Cytoplasmic Domain

  2011influential citation
• Optimising the Development of Antibodies as Treatment for Cancer

  2011cites this paper
• Antibody Therapy in Neurodegenerative Disease

  2010cites this paper
• Rationale and development of multispecific antibody drugs

  2010cites this paper
• Physico-chemical determinants of soluble intrabody expression in mammalian cell cytoplasm.

  2010cites this paper
• From bench to bedside: the growing use of translational research in cancer medicine.

  2010cites this paper